General Surgery News

 
 
  • ASBMRVitamin D Doesn't Prevent Calcium Drop After Gastric Bypass Sharp decreases in calcium absorption were observed even when gastric bypass patients maintained adequate vitamin D levels, with the level of decline correlating with the percentage of weight loss.
  • TCTABSORB II Sneak Peek: Bioabsorbable Stent Is Safe, Effective An interim analysis at one year suggests the everolimus-eluting stent with a bioabsorbable scaffold is safe and effective compared with Xience. Experts say that bigger studies are needed to get a real handle on its safety.
  • TCTNo Deaths With Mild/Moderate PVR: CoreValve Two-Year Data Two-year outcomes among extreme-risk patients treated with TAVR continued to show better survival and fewer strokes than historical controls. Costs of CoreValve in high-risk patients were also "acceptable."
  • TCTTAVR vs Surgery in Intermediate-Risk Patients: OBSERVANT It's one of the most hotly debated questions among interventionalists and surgeons: how will transcatheter valves stack up against SAVR in patients at lower risk for surgery?
  • TCTEmbolic Filter Reduces Cerebral Lesions During TAVI The CLEAN-TAVI study is a proof-of-concept trial showing that TAVI does appear to result in embolization of debris to the brain and that using an embolic filter can reduce the downstream embolization risk.
  • TCTPARTNER TAVR Deaths at Five Years: Sobering and Remarkable Most of the inoperable aortic-valve-disease patients from this pivotal trial died within a few years of the study's launch. But data on the limited survivors offer some insights that experts say will influence their practice.
  • Genetic 'Hotspot' Found in High-Risk Endometrial Cancer Younger patients with type I endometrial cancer who have a characteristic mutation in the CTNNB1 gene were more likely to have poor prognosis.
  • UK's NICE: No to Nab-Paclitaxel for Pancreatic Cancer The draft guidance says that the benefits of nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer do not outweigh its high costs.
  • CAPPathologists Should Review Bariatric Surgery Specimens Even routine gastric sleeve resections may uncover clinically significant histologic findings requiring treatment.
  • Proposed: A Scale for Financial AEs and Cancer Treatment A scale has been proposed for measuring financial toxicity in much the same way as oncologists use the Common Terminology Criteria for Adverse Events to document adverse events from cancer treatment.
  • New ASCO Guideline for Castration-Resistant Prostate Cancer Treatment choices with systemic therapies have increased for men with metastatic castration-resistant prostate cancer. The American Association of Clinical Oncology and Cancer Care Ontario have joined hands to issue their own guideline for these patients.
  • Study Supports Population Screening for BRCA1 and BRCA2 Half of the women who had BRCA1/BRCA2 mutations and were at high risk for breast or ovarian cancer had no family history of cancer and would be missed by conventional screening guidelines.
  • No Evidence Supporting Newer Joint Replacement Devices Five innovations in hip and knee joints showed no benefit over older models; some were associated with increased risk.
  • CAPVirus May Predispose People to Appendicitis The adenovirus was found in 14% of patients who had an appendectomy, say researchers.
  • Gastric Banding Linked to Mycobacterium Infections During the last 6 years, rapidly growing mycobacteria infections have begun to show up after gastric banding surgery in Australia without a clear identification of the source.
  • The 'Family Business' Behind the Flurry of PD-1 Inhibitors Discoveries from a duo of scientists at the Dana-Farber Cancer Center and Harvard Medical School have contributed to understanding how tumors hijack the PD-1 pathway and evade immune recognition. Their patents were licensed nonexclusively to 7 pharmaceutical companies, helping spawn the flurry of PD-1 inhibitors in cancer immunotherapy.
  • Renal Cancer Rates Rising in US Children, Teens Survey of pediatric cancer in the US indicates that overall cancer rates have remained stable, but incidence rates are rising for some cancers, including renal carcinoma.
  • French Company Carmat Fits Second Patient With Artificial Heart French company Carmat said on Monday it had fitted a second patient with one of its artificial hearts and would continue clinical trials on two more patients.
  • EASDWorld's Largest Diabetes Meeting, EASD, Turns 50 This Year Close to 20,000 researchers and clinicians will gather in Vienna next week to attend the 50th EASD meeting, which promises to feature exciting coverage of the latest hot topics in the field of diabetes.
  • SSIs for Kids Down by 58% With Better Prep, Antibiotic Timing Children's surgical site infections dropped by 58% at pediatric hospitals in Ohio that used interventions focused on skin preparation and disinfection and on the timing of preoperative antibiotics.